Stem cell-based kits will mimic human brain in a dish.
ATHENS, Ga., December 3, 2014 -- The U.S. Environmental Protection Agency (EPA) announced that ArunA Biomedical is among nine small businesses identified to share $3 million in research funding to help the EPA bring green technology initiatives to the marketplace.
The research is funded via a two-phase Small Business Innovative Research (SBIR) program.
During the award period, ArunA will expand commercial production capacity of human pluripotent stem cell derived neurons and astrocytes successfully developed through Phase I support. The multi-cell based technology is being used to create validated environmental toxin screening kits designed to address the need for rapid, cost effective early identification of potentially harmful toxins.
"ArunA's novel human stem cell based systems recapitulate the human brain condition and could potentially reduce animal model use with translatable human high throughput screening in a dish. The use of these multi-cell screening systems could profoundly change our understanding of how chemicals affect the human brain," said CSO Steven Stice.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Lab Tools, Solutions & Services|
|Publication:||Stem Cell Lab World|
|Date:||Dec 15, 2014|
|Previous Article:||Precise targeted RNASeq assays.|
|Next Article:||Global stem cell market to grow at CAGR of 24.2% to 2019.|